Our mission is to provide easy-to-use and reliable Al-based solutions for the diagnosis, monitoring, and management of respiratory diseases.
Pneumonia is the
1st cause of mortality in children (<5yo)
with 1 death every 30seconds
Source: Lorem ipsum
Asthma is the
most common chronic disease in childhood
affecting >10% of children
Source: Lorem ipsum
COPD affects
251 millions people killing over 3.3millions persons each year
Source: Lorem ipsum
The Problem
A Public Health Crisis
Lung sounds, oxygen blood saturation, heart rate, and temperature are simultaneously transmitted to an intuitive mobile app for real-time analysis and recognition of respiratory acoustic signatures by Al algorithms. The app not only informs the user on the likely diagnosis, but also gives the severity of the disease and suggests the best care pathway.
Our unique AI-based approach empowers healthcare professionals and patients themselves to perform rapid pulmonary screening to properly manage respiratory conditions. Onescope offers a decentralized solution that lowers healthcare costs and improves patient outcomes.
Outdated tools, mounting costs
Respiratory diseases affect over 500mn people globally and cost in the U.S. alone $170bn each year. And yet, the stethoscope, which remains the most widely used diagnostic device, has not evolved in over two centuries. leaving lung auscultation highly subjective.
Missed or delayed diagnoses
Unnecessary referrals
Rising
costs
Transform respiratory care
Onescope’s mission is to transform respiratory care with two primary objectives.
First, we aim to democratize high-quality medicine in Low-and Middle-Income Countries (LMICs) by offering an affordable, easy-to-use, and portable solution, bridging the gap in respiratory disease diagnosis for underserved populations.
Second, we focus on enhancing remote patient monitoring in high-income countries to improve patient outcomes and reduce healthcare costs associated with chronic respiratory diseases. Pneumoscope empowers healthcare professionals and patients with rapid pulmonary screenings, real-time analysis, and personalized care recommendations, facilitating proactive disease management and benefiting both patients and healthcare systems.
